Dopaminergic and serotonergic autoreceptor stimulation effects are equivalent and additive in the suppression of spontaneous and cocaine induced locomotor activity

被引:44
作者
Carey, RJ
DePalma, G
Damianopoulos, E
Hopkins, A
Shanahan, A
Müller, CP
Huston, JP
机构
[1] Vet Adm Med Ctr, Res & Dev, Syracuse, NY 13210 USA
[2] Upstate Med Univ, Syracuse, NY USA
[3] Univ Dusseldorf, Inst Physiol Psychol 1, D-4000 Dusseldorf, Germany
[4] Univ Dusseldorf, Ctr Biol & Med Res, D-4000 Dusseldorf, Germany
关键词
cocaine; locomotion; dopamine; serotonin; rat; apomorphine; 8-OHDPAT; WAY; 100635;
D O I
10.1016/j.brainres.2004.05.091
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We used the D-2 receptor agonist, apomorphine (APO) and the 5-HT1A receptor agonist, 8-OHDPAT (8OH) in a low dose range to stimulate autoreceptors and in this way assess the separate and combined effects of reduced DA and 5-HT activity upon spontaneous and cocaine induced locomotor behavior. Two separate experiments were conducted. In the first experiment, separate groups of rats (N = 10) were tested with either saline, 8OH, APO or 8OH plus APO (0.01, 0.025, 0.05 mg/kg). At 0.05 mg/kg, 8OH and APO induced similar dose related decreases (up to approximately 50%) in locomotor activity. The combined 8OH plus APO treatment induced dose-related decreases in locomotion (approximately 90%). At the 0.05 mg/kg dose level, the drug treatments given separately blocked cocaine induced increases in activity and the 8OH and APO inhibitory effects were again additive. In the second experiment, separate groups (N = 10) received saline, 0.05 mg/kg APO, 0.05 mg/kg 8OH or 0.05 mg/kg APO plus 0.05 mg/kg 8OH. As in the first experiment, the 8OH and APO given separately reduced locomotor activity by approximately 50% and when given together, locomotor activity was virtually eliminated (reduced 80-90%). When the combined APO/8OH group also received the 5-HT1A antagonist, WAY 100635 (0.05 mg/kg), the effect on activity was equivalent to 0.05 mg/kg APO alone. Ex vivo neurochemical measurement of dopamine (DA) and serotonin (5-HT) metabolism confirmed that the APO decreased DA turnover, 8OH decreased 5-HT turnover and the combined treatment reduced both the DA and 5-HT turnover. Thus, for both spontaneous and cocaine induced locomotor behavior, the low dose 8OH and APO treatments suppressed locomotor activity and these effects were additive. These findings indicate that DA and 5-HT systems contribute separately to motoric activation. These results suggest that it is important to consider both DA and 5-HT contributions to disorders of motoric impoverishment such as Parkinson's disease as well as to hyperkinetic states such as those induced by stimulant drugs. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:134 / 143
页数:10
相关论文
共 46 条
[1]  
Aghajanian G.K., 1973, FRONTIERS CATECHOLAM, P643
[2]   BEHAVIORAL AND BIOCHEMICAL EFFECTS OF THE 5-HT1A RECEPTOR AGONISTS FLESINOXAN AND 8-OH-DPAT IN THE RAT [J].
AHLENIUS, S ;
LARSSON, K ;
WIJKSTROM, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 200 (2-3) :259-266
[3]  
BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[4]  
BLIER P, 1993, J PHARMACOL EXP THER, V265, P7
[5]   MODIFICATION OF 5-HT NEURON PROPERTIES BY SUSTAINED ADMINISTRATION OF THE 5-HT1A AGONIST GEPIRONE - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
BLIER, P ;
DEMONTIGNY, C .
SYNAPSE, 1987, 1 (05) :470-480
[6]  
BLIER P, 1993, J PHARMACOL EXP THER, V265, P16
[7]   A simple and reliable method for the positive identification of pavlovian conditioned cocaine effects in open-field behavior [J].
Carey, R ;
Gui, JM .
JOURNAL OF NEUROSCIENCE METHODS, 1997, 73 (01) :1-8
[8]   8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol [J].
Carey, R ;
Damianopoulos, E ;
De Palma, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 66 (04) :863-872
[9]   The 5-HT1A antagonist WAY 100635 can block the low-dose locomotor stimulant effects of cocaine [J].
Carey, R ;
Damianopoulos, E ;
DePalma, G .
BRAIN RESEARCH, 2000, 862 (1-2) :242-246
[10]  
CARLSSON A, 1993, ADV NEUROL, V60, P1